Spinethera Inc.

Plymouth, MN

UEI
GBWBLWKNCHY5
CAGE
6SCG3
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
15600 Medina Rd, Plymouth, MN 55447, USA
Website
frenellepharma.com
Founded
2012
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
GLP toxicology testing and phase 2/3 development for a nonopioid, injectable drug product for the treatment of… W81XWH2110425 Defense Health Agency $4,970,751
Susatined-release injectible steroid to reduce frequent epidural injections for back pain W81XWH1710014 Medical Command (Army) $1,976,194
Sustained release steroid to reduce frequent epidural injections for back pain R43AR067550 National Institutes of Health $224,577

Quick answers

Is Spinethera Inc. registered in SAM.gov?

Yes. Spinethera Inc.'s SAM.gov registration is active through March 13, 2027.

What is Spinethera Inc.'s most recent federal award?

Spinethera Inc.'s most recent federal grant award is GLP toxicology testing and phase 2/3 development for a nonopioid, injectable drug product for the treatment of… (W81XWH2110425), from Defense Health Agency, on June 1, 2021.

On GovTribe

See Spinethera Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login